(Q51080894)

29 March 2018

title

Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks. (English)

1 reference

29 March 2018

1 reference

Nardi AE

1

1 reference

29 March 2018

Valença AM

2

1 reference

29 March 2018

Nascimento I

3

1 reference

29 March 2018

Mezzasalma MA

4

1 reference

29 March 2018

Zin WA

5

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 May 2000

1 reference

29 March 2018

published in

Psychiatry Research

1 reference

29 March 2018

volume

94

1 reference

29 March 2018

issue

2

1 reference

29 March 2018

page(s)

179-184

1 reference

29 March 2018

Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Antipanic effect of fluoxetine measured by CO2 challenge test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Antipanic effect of clonazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

CO2 vulnerability in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Specific sensitivity of patients with panic attacks to carbon dioxide inhalation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Carbon dioxide induced panic attacks and short term clonazepam treatment. Preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Carbon dioxide hypersensitivity, hyperventilation, and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Diagnostic and substance specificity of carbon-dioxide-induced panic.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Attenuation of carbon dioxide-induced panic after clonazepam treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Fluvoxamine attenuates panic induced by 35% CO2 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Five percent carbon dioxide challenge: valid analogue and marker of panic disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Alprazolam blockade of CO2-provoked panic in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900135-9

7 January 2021

10.1016/S0165-1781(00)00135-9

Identifiers

DOI

1 reference

29 March 2018

1 reference

29 March 2018